Marie-Françoise Bordes

Inhibition of Tumor Angiogenesis and Growth by a Small-Molecule Multi-FGF Receptor Blocker with Allosteric Properties

Françoise Bono, Frederik De Smet, Corentin Herbert et al. · Cancer Cell · 2013 · 146 citations · Full text

Angiogenesis, Medicine, Natural Sciences +12

New Orally Active Non-Peptide Fibrinogen Receptor (GpIIb-IIIa) Antagonists:  Identification of Ethyl 3-[<i>N</i>-[4-[4-[Amino[(ethoxycarbonyl)imino]methyl]phenyl]- 1,3-thiazol-2-yl]-<i>N</i>-[1-[(ethoxycarbonyl)methyl]piperid-4-yl]amino]propionate (SR 121787) as a Potent and Long-Acting Antithrombotic Agent

Alain Badorc, Marie-Françoise Bordes, P. DE COINTET et al. · Journal of Medicinal Chemistry · 1997 · 127 citations · Full text

Sr 121787, Immunology, Adp-induced Aggregation +22

<i>N</i>-[6-(4-Butanoyl-5-methyl-1<i>H</i>-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1<i>H</i>-indole-3-carboxamide (SAR216471), a Novel Intravenous and Oral, Reversible, and Directly Acting P2Y12 Antagonist

Christophe Boldron, Angélina Besse, Marie-Françoise Bordes et al. · Journal of Medicinal Chemistry · 2014 · 49 citations · Full text

Acting P2y12 Antagonist, Immunology, Pharmacotherapy +22

SR 121787, a New Orally Active Fibrinogen Receptor Antagonist

Pierre Savi, Alain Badorc, Alain Lalé et al. · Thrombosis and Haemostasis · 1998 · 15 citations